Trial Profile
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2022
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Proteinuria; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms 1981 GLP
- 28 Oct 2022 Status changed from not yet recruiting to discontinued.
- 01 Feb 2017 New trial record